Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
U287111-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $20.90 | |
U287111-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $86.90 | |
U287111-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $162.90 | |
U287111-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $652.90 |
RXR antagonist
Synonyms | BS-17614 | AKOS024457539 | SCHEMBL19119381 | GTPL2816 | compound 10e [PMID: 19408900] | (2E)-3-{4-hydroxy-3-[5,5,8,8-tetramethyl-3-(pentyloxy)-5,6,7,8-tetrahydronaphthalen-2-yl]phenyl}prop-2-enoic acid | Q27089116 | UVI3003 | UVI-3003 | (E)-3-[4-hydroxy-3 |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | RXR antagonist; displays high RXR binding affinity. Does not affect the corepressor interaction capacity of the RARαsubunit within the context of the RAR-RXR heterodimer. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of Retinoid X receptor-α;Antagonist of Retinoid X receptor-β |
Product Description | product description: UVI 3003 is a highly selective antagonist of retinoid X receptor (RXR), and inhibits xenopus and human RXRα with IC50 of 0.22 μM and 0.24 μM in Cos7 cells, respectively. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (E)-3-[4-hydroxy-3-(5,5,8,8-tetramethyl-3-pentoxy-6,7-dihydronaphthalen-2-yl)phenyl]prop-2-enoic acid |
---|---|
INCHI | InChI=1S/C28H36O4/c1-6-7-8-15-32-25-18-23-22(27(2,3)13-14-28(23,4)5)17-21(25)20-16-19(9-11-24(20)29)10-12-26(30)31/h9-12,16-18,29H,6-8,13-15H2,1-5H3,(H,30,31)/b12-10+ |
InChi Key | APJSHECCIRQQDV-ZRDIBKRKSA-N |
Canonical SMILES | CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)C=CC(=O)O)O)C(CCC2(C)C)(C)C |
Isomeric SMILES | CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C |
PubChem CID | 44566108 |
Molecular Weight | 436.58 |
PubChem CID | 44566108 |
---|---|
ChEMBL Ligand | CHEMBL521955 |
CAS Registry No. | 847239-17-2 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2418649 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418650 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418651 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418673 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418674 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418675 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418676 | Certificate of Analysis | Jan 06, 2024 | U287111 |
B2418677 | Certificate of Analysis | Jan 06, 2024 | U287111 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 43.66, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 43.66, Max Conc. mM: 100 |
---|
RIDADR | NONHforallmodesoftransport |
---|
1. Pérez Santín E, Germain P, Quillard F, Khanwalkar H, Rodríguez-Barrios F, Gronemeyer H, de Lera AR, Bourguet W. (2009) Modulating retinoid X receptor with a series of (E)-3-[4-hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic acids and their 4-alkoxy isomers.. J Med Chem, 52 (10): (3150-8). [PMID:19408900] [10.1021/op500134e] |